COVID-19 Impact on Global CD19 (Antibody) Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 23-Jun-2020
No. of pages: 131
Inquire Before Buying

This report focuses on the global CD19(Antibody) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CD19(Antibody) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

- Abbexa Ltd(UK)

- Aviva Systems Biology Corporation(US)

- Boster Biological Technology(US)

- Biobyt(UK)

- Bio-Rad(US)

- Bioss Antibodies(US)

- BioLegend(US)

- Lifespan Biosciences(US)

- ProteoGenix(FR)

- Novus Biologicals(US)

- ProSci(US)

- Proteintech(US)

- R&D Systems(US)

- Thermo Fisher Scientific(US)

- USBiological(US)

- BethylLaboratories(US)

- Genetex(US)

- Rockland(US)

- SouthernBiotech(US)

- Stemcell(CA)

- St John's Laboratory Ltd(UK)

Market segment by Type, the product can be split into

- Above 90%

- Above 95%

- Above 99%

- Others

Market segment by Application, split into

- Biopharmaceutical Companies

- Hospitals

- Bioscience Research Institutions

- Others

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global CD19(Antibody) status, future forecast, growth opportunity, key market and key players.

- To present the CD19(Antibody) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of CD19(Antibody) are as follows:

- History Year: 2015-2019

- Base Year: 2019

- Estimated Year: 2020

- Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

COVID-19 Impact on Global CD19 (Antibody) Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CD19(Antibody) Revenue
1.4 Market Analysis by Type
1.4.1 Global CD19(Antibody) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Above 90%
1.4.3 Above 95%
1.4.4 Above 99%
1.4.5 Others
1.5 Market by Application
1.5.1 Global CD19(Antibody) Market Share by Application: 2020 VS 2026
1.5.2 Biopharmaceutical Companies
1.5.3 Hospitals
1.5.4 Bioscience Research Institutions
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): CD19(Antibody) Industry Impact
1.6.1 How the Covid-19 is Affecting the CD19(Antibody) Industry
1.6.1.1 CD19(Antibody) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and CD19(Antibody) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for CD19(Antibody) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 CD19(Antibody) Market Perspective (2015-2026)
2.2 CD19(Antibody) Growth Trends by Regions
2.2.1 CD19(Antibody) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CD19(Antibody) Historic Market Share by Regions (2015-2020)
2.2.3 CD19(Antibody) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 CD19(Antibody) Market Growth Strategy
2.3.6 Primary Interviews with Key CD19(Antibody) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top CD19(Antibody) Players by Market Size
3.1.1 Global Top CD19(Antibody) Players by Revenue (2015-2020)
3.1.2 Global CD19(Antibody) Revenue Market Share by Players (2015-2020)
3.1.3 Global CD19(Antibody) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global CD19(Antibody) Market Concentration Ratio
3.2.1 Global CD19(Antibody) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by CD19(Antibody) Revenue in 2019
3.3 CD19(Antibody) Key Players Head office and Area Served
3.4 Key Players CD19(Antibody) Product Solution and Service
3.5 Date of Enter into CD19(Antibody) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global CD19(Antibody) Historic Market Size by Type (2015-2020)
4.2 Global CD19(Antibody) Forecasted Market Size by Type (2021-2026)
5 CD19(Antibody) Breakdown Data by Application (2015-2026)
5.1 Global CD19(Antibody) Market Size by Application (2015-2020)
5.2 Global CD19(Antibody) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America CD19(Antibody) Market Size (2015-2020)
6.2 CD19(Antibody) Key Players in North America (2019-2020)
6.3 North America CD19(Antibody) Market Size by Type (2015-2020)
6.4 North America CD19(Antibody) Market Size by Application (2015-2020)
7 Europe
7.1 Europe CD19(Antibody) Market Size (2015-2020)
7.2 CD19(Antibody) Key Players in Europe (2019-2020)
7.3 Europe CD19(Antibody) Market Size by Type (2015-2020)
7.4 Europe CD19(Antibody) Market Size by Application (2015-2020)
8 China
8.1 China CD19(Antibody) Market Size (2015-2020)
8.2 CD19(Antibody) Key Players in China (2019-2020)
8.3 China CD19(Antibody) Market Size by Type (2015-2020)
8.4 China CD19(Antibody) Market Size by Application (2015-2020)
9 Japan
9.1 Japan CD19(Antibody) Market Size (2015-2020)
9.2 CD19(Antibody) Key Players in Japan (2019-2020)
9.3 Japan CD19(Antibody) Market Size by Type (2015-2020)
9.4 Japan CD19(Antibody) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia CD19(Antibody) Market Size (2015-2020)
10.2 CD19(Antibody) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia CD19(Antibody) Market Size by Type (2015-2020)
10.4 Southeast Asia CD19(Antibody) Market Size by Application (2015-2020)
11 India
11.1 India CD19(Antibody) Market Size (2015-2020)
11.2 CD19(Antibody) Key Players in India (2019-2020)
11.3 India CD19(Antibody) Market Size by Type (2015-2020)
11.4 India CD19(Antibody) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America CD19(Antibody) Market Size (2015-2020)
12.2 CD19(Antibody) Key Players in Central & South America (2019-2020)
12.3 Central & South America CD19(Antibody) Market Size by Type (2015-2020)
12.4 Central & South America CD19(Antibody) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbexa Ltd(UK)
13.1.1 Abbexa Ltd(UK) Company Details
13.1.2 Abbexa Ltd(UK) Business Overview and Its Total Revenue
13.1.3 Abbexa Ltd(UK) CD19(Antibody) Introduction
13.1.4 Abbexa Ltd(UK) Revenue in CD19(Antibody) Business (2015-2020))
13.1.5 Abbexa Ltd(UK) Recent Development
13.2 Aviva Systems Biology Corporation(US)
13.2.1 Aviva Systems Biology Corporation(US) Company Details
13.2.2 Aviva Systems Biology Corporation(US) Business Overview and Its Total Revenue
13.2.3 Aviva Systems Biology Corporation(US) CD19(Antibody) Introduction
13.2.4 Aviva Systems Biology Corporation(US) Revenue in CD19(Antibody) Business (2015-2020)
13.2.5 Aviva Systems Biology Corporation(US) Recent Development
13.3 Boster Biological Technology(US)
13.3.1 Boster Biological Technology(US) Company Details
13.3.2 Boster Biological Technology(US) Business Overview and Its Total Revenue
13.3.3 Boster Biological Technology(US) CD19(Antibody) Introduction
13.3.4 Boster Biological Technology(US) Revenue in CD19(Antibody) Business (2015-2020)
13.3.5 Boster Biological Technology(US) Recent Development
13.4 Biobyt(UK)
13.4.1 Biobyt(UK) Company Details
13.4.2 Biobyt(UK) Business Overview and Its Total Revenue
13.4.3 Biobyt(UK) CD19(Antibody) Introduction
13.4.4 Biobyt(UK) Revenue in CD19(Antibody) Business (2015-2020)
13.4.5 Biobyt(UK) Recent Development
13.5 Bio-Rad(US)
13.5.1 Bio-Rad(US) Company Details
13.5.2 Bio-Rad(US) Business Overview and Its Total Revenue
13.5.3 Bio-Rad(US) CD19(Antibody) Introduction
13.5.4 Bio-Rad(US) Revenue in CD19(Antibody) Business (2015-2020)
13.5.5 Bio-Rad(US) Recent Development
13.6 Bioss Antibodies(US)
13.6.1 Bioss Antibodies(US) Company Details
13.6.2 Bioss Antibodies(US) Business Overview and Its Total Revenue
13.6.3 Bioss Antibodies(US) CD19(Antibody) Introduction
13.6.4 Bioss Antibodies(US) Revenue in CD19(Antibody) Business (2015-2020)
13.6.5 Bioss Antibodies(US) Recent Development
13.7 BioLegend(US)
13.7.1 BioLegend(US) Company Details
13.7.2 BioLegend(US) Business Overview and Its Total Revenue
13.7.3 BioLegend(US) CD19(Antibody) Introduction
13.7.4 BioLegend(US) Revenue in CD19(Antibody) Business (2015-2020)
13.7.5 BioLegend(US) Recent Development
13.8 Lifespan Biosciences(US)
13.8.1 Lifespan Biosciences(US) Company Details
13.8.2 Lifespan Biosciences(US) Business Overview and Its Total Revenue
13.8.3 Lifespan Biosciences(US) CD19(Antibody) Introduction
13.8.4 Lifespan Biosciences(US) Revenue in CD19(Antibody) Business (2015-2020)
13.8.5 Lifespan Biosciences(US) Recent Development
13.9 ProteoGenix(FR)
13.9.1 ProteoGenix(FR) Company Details
13.9.2 ProteoGenix(FR) Business Overview and Its Total Revenue
13.9.3 ProteoGenix(FR) CD19(Antibody) Introduction
13.9.4 ProteoGenix(FR) Revenue in CD19(Antibody) Business (2015-2020)
13.9.5 ProteoGenix(FR) Recent Development
13.10 Novus Biologicals(US)
13.10.1 Novus Biologicals(US) Company Details
13.10.2 Novus Biologicals(US) Business Overview and Its Total Revenue
13.10.3 Novus Biologicals(US) CD19(Antibody) Introduction
13.10.4 Novus Biologicals(US) Revenue in CD19(Antibody) Business (2015-2020)
13.10.5 Novus Biologicals(US) Recent Development
13.11 ProSci(US)
10.11.1 ProSci(US) Company Details
10.11.2 ProSci(US) Business Overview and Its Total Revenue
10.11.3 ProSci(US) CD19(Antibody) Introduction
10.11.4 ProSci(US) Revenue in CD19(Antibody) Business (2015-2020)
10.11.5 ProSci(US) Recent Development
13.12 Proteintech(US)
10.12.1 Proteintech(US) Company Details
10.12.2 Proteintech(US) Business Overview and Its Total Revenue
10.12.3 Proteintech(US) CD19(Antibody) Introduction
10.12.4 Proteintech(US) Revenue in CD19(Antibody) Business (2015-2020)
10.12.5 Proteintech(US) Recent Development
13.13 R&D Systems(US)
10.13.1 R&D Systems(US) Company Details
10.13.2 R&D Systems(US) Business Overview and Its Total Revenue
10.13.3 R&D Systems(US) CD19(Antibody) Introduction
10.13.4 R&D Systems(US) Revenue in CD19(Antibody) Business (2015-2020)
10.13.5 R&D Systems(US) Recent Development
13.14 Thermo Fisher Scientific(US)
10.14.1 Thermo Fisher Scientific(US) Company Details
10.14.2 Thermo Fisher Scientific(US) Business Overview and Its Total Revenue
10.14.3 Thermo Fisher Scientific(US) CD19(Antibody) Introduction
10.14.4 Thermo Fisher Scientific(US) Revenue in CD19(Antibody) Business (2015-2020)
10.14.5 Thermo Fisher Scientific(US) Recent Development
13.15 USBiological(US)
10.15.1 USBiological(US) Company Details
10.15.2 USBiological(US) Business Overview and Its Total Revenue
10.15.3 USBiological(US) CD19(Antibody) Introduction
10.15.4 USBiological(US) Revenue in CD19(Antibody) Business (2015-2020)
10.15.5 USBiological(US) Recent Development
13.16 BethylLaboratories(US)
10.16.1 BethylLaboratories(US) Company Details
10.16.2 BethylLaboratories(US) Business Overview and Its Total Revenue
10.16.3 BethylLaboratories(US) CD19(Antibody) Introduction
10.16.4 BethylLaboratories(US) Revenue in CD19(Antibody) Business (2015-2020)
10.16.5 BethylLaboratories(US) Recent Development
13.17 Genetex(US)
10.17.1 Genetex(US) Company Details
10.17.2 Genetex(US) Business Overview and Its Total Revenue
10.17.3 Genetex(US) CD19(Antibody) Introduction
10.17.4 Genetex(US) Revenue in CD19(Antibody) Business (2015-2020)
10.17.5 Genetex(US) Recent Development
13.18 Rockland(US)
10.18.1 Rockland(US) Company Details
10.18.2 Rockland(US) Business Overview and Its Total Revenue
10.18.3 Rockland(US) CD19(Antibody) Introduction
10.18.4 Rockland(US) Revenue in CD19(Antibody) Business (2015-2020)
10.18.5 Rockland(US) Recent Development
13.19 SouthernBiotech(US)
10.19.1 SouthernBiotech(US) Company Details
10.19.2 SouthernBiotech(US) Business Overview and Its Total Revenue
10.19.3 SouthernBiotech(US) CD19(Antibody) Introduction
10.19.4 SouthernBiotech(US) Revenue in CD19(Antibody) Business (2015-2020)
10.19.5 SouthernBiotech(US) Recent Development
13.20 Stemcell(CA)
10.20.1 Stemcell(CA) Company Details
10.20.2 Stemcell(CA) Business Overview and Its Total Revenue
10.20.3 Stemcell(CA) CD19(Antibody) Introduction
10.20.4 Stemcell(CA) Revenue in CD19(Antibody) Business (2015-2020)
10.20.5 Stemcell(CA) Recent Development
13.21 St John's Laboratory Ltd(UK)
10.21.1 St John's Laboratory Ltd(UK) Company Details
10.21.2 St John's Laboratory Ltd(UK) Business Overview and Its Total Revenue
10.21.3 St John's Laboratory Ltd(UK) CD19(Antibody) Introduction
10.21.4 St John's Laboratory Ltd(UK) Revenue in CD19(Antibody) Business (2015-2020)
10.21.5 St John's Laboratory Ltd(UK) Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. CD19(Antibody) Key Market Segments
Table 2. Key Players Covered: Ranking by CD19(Antibody) Revenue
Table 3. Ranking of Global Top CD19(Antibody) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global CD19(Antibody) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Above 90%
Table 6. Key Players of Above 95%
Table 7. Key Players of Above 99%
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four CD19(Antibody) Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for CD19(Antibody) Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for CD19(Antibody) Players to Combat Covid-19 Impact
Table 14. Global CD19(Antibody) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global CD19(Antibody) Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global CD19(Antibody) Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global CD19(Antibody) Market Share by Regions (2015-2020)
Table 18. Global CD19(Antibody) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global CD19(Antibody) Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. CD19(Antibody) Market Growth Strategy
Table 24. Main Points Interviewed from Key CD19(Antibody) Players
Table 25. Global CD19(Antibody) Revenue by Players (2015-2020) (Million US$)
Table 26. Global CD19(Antibody) Market Share by Players (2015-2020)
Table 27. Global Top CD19(Antibody) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD19(Antibody) as of 2019)
Table 28. Global CD19(Antibody) by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players CD19(Antibody) Product Solution and Service
Table 31. Date of Enter into CD19(Antibody) Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global CD19(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 34. Global CD19(Antibody) Market Size Share by Type (2015-2020)
Table 35. Global CD19(Antibody) Revenue Market Share by Type (2021-2026)
Table 36. Global CD19(Antibody) Market Size Share by Application (2015-2020)
Table 37. Global CD19(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 38. Global CD19(Antibody) Market Size Share by Application (2021-2026)
Table 39. North America Key Players CD19(Antibody) Revenue (2019-2020) (Million US$)
Table 40. North America Key Players CD19(Antibody) Market Share (2019-2020)
Table 41. North America CD19(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 42. North America CD19(Antibody) Market Share by Type (2015-2020)
Table 43. North America CD19(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 44. North America CD19(Antibody) Market Share by Application (2015-2020)
Table 45. Europe Key Players CD19(Antibody) Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players CD19(Antibody) Market Share (2019-2020)
Table 47. Europe CD19(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 48. Europe CD19(Antibody) Market Share by Type (2015-2020)
Table 49. Europe CD19(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 50. Europe CD19(Antibody) Market Share by Application (2015-2020)
Table 51. China Key Players CD19(Antibody) Revenue (2019-2020) (Million US$)
Table 52. China Key Players CD19(Antibody) Market Share (2019-2020)
Table 53. China CD19(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 54. China CD19(Antibody) Market Share by Type (2015-2020)
Table 55. China CD19(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 56. China CD19(Antibody) Market Share by Application (2015-2020)
Table 57. Japan Key Players CD19(Antibody) Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players CD19(Antibody) Market Share (2019-2020)
Table 59. Japan CD19(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 60. Japan CD19(Antibody) Market Share by Type (2015-2020)
Table 61. Japan CD19(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 62. Japan CD19(Antibody) Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players CD19(Antibody) Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players CD19(Antibody) Market Share (2019-2020)
Table 65. Southeast Asia CD19(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia CD19(Antibody) Market Share by Type (2015-2020)
Table 67. Southeast Asia CD19(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia CD19(Antibody) Market Share by Application (2015-2020)
Table 69. India Key Players CD19(Antibody) Revenue (2019-2020) (Million US$)
Table 70. India Key Players CD19(Antibody) Market Share (2019-2020)
Table 71. India CD19(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 72. India CD19(Antibody) Market Share by Type (2015-2020)
Table 73. India CD19(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 74. India CD19(Antibody) Market Share by Application (2015-2020)
Table 75. Central & South America Key Players CD19(Antibody) Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players CD19(Antibody) Market Share (2019-2020)
Table 77. Central & South America CD19(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America CD19(Antibody) Market Share by Type (2015-2020)
Table 79. Central & South America CD19(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America CD19(Antibody) Market Share by Application (2015-2020)
Table 81. Abbexa Ltd(UK) Company Details
Table 82. Abbexa Ltd(UK) Business Overview
Table 83. Abbexa Ltd(UK) Product
Table 84. Abbexa Ltd(UK) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 85. Abbexa Ltd(UK) Recent Development
Table 86. Aviva Systems Biology Corporation(US) Company Details
Table 87. Aviva Systems Biology Corporation(US) Business Overview
Table 88. Aviva Systems Biology Corporation(US) Product
Table 89. Aviva Systems Biology Corporation(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 90. Aviva Systems Biology Corporation(US) Recent Development
Table 91. Boster Biological Technology(US) Company Details
Table 92. Boster Biological Technology(US) Business Overview
Table 93. Boster Biological Technology(US) Product
Table 94. Boster Biological Technology(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 95. Boster Biological Technology(US) Recent Development
Table 96. Biobyt(UK) Company Details
Table 97. Biobyt(UK) Business Overview
Table 98. Biobyt(UK) Product
Table 99. Biobyt(UK) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 100. Biobyt(UK) Recent Development
Table 101. Bio-Rad(US) Company Details
Table 102. Bio-Rad(US) Business Overview
Table 103. Bio-Rad(US) Product
Table 104. Bio-Rad(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 105. Bio-Rad(US) Recent Development
Table 106. Bioss Antibodies(US) Company Details
Table 107. Bioss Antibodies(US) Business Overview
Table 108. Bioss Antibodies(US) Product
Table 109. Bioss Antibodies(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 110. Bioss Antibodies(US) Recent Development
Table 111. BioLegend(US) Company Details
Table 112. BioLegend(US) Business Overview
Table 113. BioLegend(US) Product
Table 114. BioLegend(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 115. BioLegend(US) Recent Development
Table 116. Lifespan Biosciences(US) Business Overview
Table 117. Lifespan Biosciences(US) Product
Table 118. Lifespan Biosciences(US) Company Details
Table 119. Lifespan Biosciences(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 120. Lifespan Biosciences(US) Recent Development
Table 121. ProteoGenix(FR) Company Details
Table 122. ProteoGenix(FR) Business Overview
Table 123. ProteoGenix(FR) Product
Table 124. ProteoGenix(FR) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 125. ProteoGenix(FR) Recent Development
Table 126. Novus Biologicals(US) Company Details
Table 127. Novus Biologicals(US) Business Overview
Table 128. Novus Biologicals(US) Product
Table 129. Novus Biologicals(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 130. Novus Biologicals(US) Recent Development
Table 131. ProSci(US) Company Details
Table 132. ProSci(US) Business Overview
Table 133. ProSci(US) Product
Table 134. ProSci(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 135. ProSci(US) Recent Development
Table 136. Proteintech(US) Company Details
Table 137. Proteintech(US) Business Overview
Table 138. Proteintech(US) Product
Table 139. Proteintech(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 140. Proteintech(US) Recent Development
Table 141. R&D Systems(US) Company Details
Table 142. R&D Systems(US) Business Overview
Table 143. R&D Systems(US) Product
Table 144. R&D Systems(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 145. R&D Systems(US) Recent Development
Table 146. Thermo Fisher Scientific(US) Company Details
Table 147. Thermo Fisher Scientific(US) Business Overview
Table 148. Thermo Fisher Scientific(US) Product
Table 149. Thermo Fisher Scientific(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 150. Thermo Fisher Scientific(US) Recent Development
Table 151. USBiological(US) Company Details
Table 152. USBiological(US) Business Overview
Table 153. USBiological(US) Product
Table 154. USBiological(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 155. USBiological(US) Recent Development
Table 156. BethylLaboratories(US) Company Details
Table 157. BethylLaboratories(US) Business Overview
Table 158. BethylLaboratories(US) Product
Table 159. BethylLaboratories(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 160. BethylLaboratories(US) Recent Development
Table 161. Genetex(US) Company Details
Table 162. Genetex(US) Business Overview
Table 163. Genetex(US) Product
Table 164. Genetex(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 165. Genetex(US) Recent Development
Table 166. Rockland(US) Company Details
Table 167. Rockland(US) Business Overview
Table 168. Rockland(US) Product
Table 169. Rockland(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 170. Rockland(US) Recent Development
Table 171. SouthernBiotech(US) Company Details
Table 172. SouthernBiotech(US) Business Overview
Table 173. SouthernBiotech(US) Product
Table 174. SouthernBiotech(US) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 175. SouthernBiotech(US) Recent Development
Table 176. Stemcell(CA) Company Details
Table 177. Stemcell(CA) Business Overview
Table 178. Stemcell(CA) Product
Table 179. Stemcell(CA) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 180. Stemcell(CA) Recent Development
Table 181. St John's Laboratory Ltd(UK) Company Details
Table 182. St John's Laboratory Ltd(UK) Business Overview
Table 183. St John's Laboratory Ltd(UK) Product
Table 184. St John's Laboratory Ltd(UK) Revenue in CD19(Antibody) Business (2015-2020) (Million US$)
Table 185. St John's Laboratory Ltd(UK) Recent Development
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CD19(Antibody) Market Share by Type: 2020 VS 2026
Figure 2. Above 90% Features
Figure 3. Above 95% Features
Figure 4. Above 99% Features
Figure 5. Others Features
Figure 6. Global CD19(Antibody) Market Share by Application: 2020 VS 2026
Figure 7. Biopharmaceutical Companies Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Bioscience Research Institutions Case Studies
Figure 10. Others Case Studies
Figure 11. CD19(Antibody) Report Years Considered
Figure 12. Global CD19(Antibody) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global CD19(Antibody) Market Share by Regions: 2020 VS 2026
Figure 14. Global CD19(Antibody) Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global CD19(Antibody) Market Share by Players in 2019
Figure 17. Global Top CD19(Antibody) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD19(Antibody) as of 2019
Figure 18. The Top 10 and 5 Players Market Share by CD19(Antibody) Revenue in 2019
Figure 19. North America CD19(Antibody) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe CD19(Antibody) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China CD19(Antibody) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan CD19(Antibody) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia CD19(Antibody) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India CD19(Antibody) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America CD19(Antibody) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Abbexa Ltd(UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbexa Ltd(UK) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 28. Aviva Systems Biology Corporation(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Aviva Systems Biology Corporation(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 30. Boster Biological Technology(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Boster Biological Technology(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 32. Biobyt(UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Biobyt(UK) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 34. Bio-Rad(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Bio-Rad(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 36. Bioss Antibodies(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bioss Antibodies(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 38. BioLegend(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. BioLegend(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 40. Lifespan Biosciences(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Lifespan Biosciences(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 42. ProteoGenix(FR) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. ProteoGenix(FR) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 44. Novus Biologicals(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Novus Biologicals(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 46. ProSci(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. ProSci(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 48. Proteintech(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Proteintech(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 50. R&D Systems(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. R&D Systems(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 52. Thermo Fisher Scientific(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Thermo Fisher Scientific(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 54. USBiological(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. USBiological(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 56. BethylLaboratories(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. BethylLaboratories(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 58. Genetex(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Genetex(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 60. Rockland(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Rockland(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 62. SouthernBiotech(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. SouthernBiotech(US) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 64. Stemcell(CA) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Stemcell(CA) Revenue Growth Rate in CD19(Antibody) Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs